The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

Jeffrey G. Black net worth and biography

Jeffrey Black Biography and Net Worth

CFO of Alphatec

Jeffrey G. Black serves as Chief Financial Officer, Executive Vice President of the Company. Prior to joining us, from September 2015 until March 2017, Mr. Black was Chief Financial Officer of Applied Proteomics, Inc., a privately-held, non-invasive, proteomics-based diagnostics company. From April 2014 until September 2015, Mr. Black was Chief Financial Officer of AltheaDx, Inc., a privately-held pharmacogenetics diagnostics company. Before joining AltheaDx, Mr. Black was employed by Verenium Corporation (formerly Diversa Corporation), a clean technology company, where he served as Chief Accounting Officer from April 2005 until February 2011 and Chief Financial Officer from February 2011 through December 2013. He also served as Executive Director of Accounting and Corporate Controller of Ionis Pharmaceuticals (formerly ISIS Pharmaceuticals), a drug discovery company, as well as in finance and controller roles at Lightspan, Inc., TriTeal Corporation and Chiron Mimotopes Peptide Systems, LLC. He is a Certified Public Accountant (inactive), and is a member of the Board of Directors of Cellana, Inc., a San Diego-based algae bioproducts company. Mr. Black received a B.S. degree in Business from the University of Arizona.

What is Jeffrey G. Black's net worth?: The estimated net worth of Jeffrey G. Black is at least $437,529.52 as of May 18th, 2023. Mr. Black owns 43,492 shares of Alphatec stock worth more than $437,530 as of November 23rd. This net worth estimate does not reflect any other investments that Mr. Black may own. Learn More about Jeffrey G. Black's net worth.
How do I contact Jeffrey G. Black?: The corporate mailing address for Mr. Black and other Alphatec executives is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. Alphatec can also be reached via phone at (760) 431-9286 and via email at [email protected]. Learn More on Jeffrey G. Black's contact information.
Has Jeffrey G. Black been buying or selling shares of Alphatec?: Jeffrey G. Black has not been actively trading shares of Alphatec within the last three months. Most recently, Jeffrey G. Black sold 7,000 shares of the business's stock in a transaction on Tuesday, March 9th. The shares were sold at an average price of $16.69, for a transaction totalling $116,830.00. Following the completion of the sale, the chief financial officer now directly owns 620,770 shares of the company's stock, valued at $10,360,651.30. Learn More on Jeffrey G. Black's trading history.
Who are Alphatec's active insiders?: Alphatec's insider roster includes Evan Bakst (Director), Jeffrey Black (CFO), Jason Hochberg (Director), Craig Hunsaker (EVP), Scott Lish (SVP), Patrick Miles (CEO), David Mowry (Director), David Pelizzon (Director), Jennifer Pritzker (Major Shareholder), Paul Segal (Major Shareholder), David Sponsel (EVP), and James Tullis (Director). Learn More on Alphatec's active insiders.
Are insiders buying or selling shares of Alphatec?: In the last twelve months, Alphatec insiders bought shares 3 times. They purchased a total of 85,000 shares worth more than $743,050.00. In the last twelve months, insiders at the medical technology company sold shares 12 times. They sold a total of 340,301 shares worth more than $4,593,019.43. The most recent insider tranaction occured on August, 21st when Director David M Demski bought 50,000 shares worth more than $283,500.00. Insiders at Alphatec own 22.8% of the company. Learn More about insider trades at Alphatec.
Information on this page was last updated on 8/21/2024.

Jeffrey G. Black Insider Trading History at Alphatec

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/9/2021	Sell	7,000	$16.69	$116,830.00	620,770
2/16/2021	Sell	25,000	$16.28	$407,000.00	627,770
8/11/2020	Sell	5,000	$6.42	$32,100.00	652,770
8/4/2020	Sell	8,929	$5.03	$44,912.87	657,770
8/2/2019	Sell	8,929	$4.75	$42,412.75	511,862
8/17/2017	Buy	5,000	$1.80	$9,000.00
8/16/2017	Buy	4,000	$1.75	$7,000.00	79,000

Jeffrey G. Black Buying and Selling Activity at Alphatec

Alphatec Company Overview

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Today's Range

Now: $10.06

$9.97

$10.40

50 Day Range

MA: $6.71

$4.98

$10.20

2 Week Range

Now: $10.06

$4.88

$17.34

Volume

1,122,129 shs

Average Volume

3,035,940 shs

Market Capitalization

$1.43 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.31

Financial Prophecy

From Porter & Company | Ad